Kun-Long Hung | Neuromuscular Disease | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Kun-Long Hung
Fu Jen Catholic University Hospital, Taiwan

Kun-Long Hung
Affiliation Fu Jen Catholic University Hospital
Country Taiwan
Scopus ID 7202728402
Documents 81
Citations 1,862
h-index 23
Subject Area Neuromuscular Disease
Event Global Diseases Research Awards

Kun-Long Hung is a Taiwan-based clinician and researcher associated with Fu Jen Catholic University Hospital. His scholarly work focuses on neuromuscular disorders, pediatric neurology, developmental diseases, genetic conditions, and neurological manifestations of emerging diseases. According to Scopus author records, he has authored more than eighty indexed publications and has accumulated substantial citation impact within the neurological sciences community.[1]

Abstract

This article presents an overview of the academic profile and research accomplishments of Kun-Long Hung. His work has contributed to the understanding of pediatric neurological disorders, rare genetic diseases, neurodevelopmental conditions, and clinical neurology. Through sustained publication activity and interdisciplinary collaboration, he has supported advancements in diagnosis, disease management, and patient care across multiple neurological specialties.[1]

Keywords

Neuromuscular Disease, Pediatric Neurology, Genetic Disorders, Developmental Delay, Clinical Neurology, Rare Diseases, Neurological Research, Global Diseases Research Awards.

Introduction

Neurological and neuromuscular disorders continue to represent significant global health challenges requiring ongoing scientific investigation. Kun-Long Hung has contributed to this field through clinical studies, translational research, and scholarly publications addressing neurological diseases affecting children and adults. His research reflects a commitment to evidence-based medicine and improved patient outcomes within specialized healthcare settings.[2]

Research Profile

The Scopus author profile of Kun-Long Hung reports 81 indexed documents, 1,862 citations, and an h-index of 23. His publication portfolio includes original research articles, editorials, reviews, and collaborative clinical studies. The breadth of his scholarly activities demonstrates long-term engagement with pediatric neurology, genetic diseases, epilepsy, developmental disorders, and neuromuscular conditions.[1]

Research Contributions

His contributions include investigations into neurofibromatosis type 1, developmental and epileptic encephalopathy, Zellweger spectrum disorders, and neurological manifestations associated with infectious diseases. These studies have supported improved understanding of disease mechanisms, diagnostic pathways, and patient management strategies. The multidisciplinary nature of this work highlights both clinical relevance and scientific value within contemporary neurological research.[3]

Publications

Published studies associated with Kun-Long Hung include investigations on neurological manifestations of SARS-CoV-2 infection in children, tubulinopathy-related developmental disorders, lenticulostriate vasculopathy in preterm infants, and molecular aspects of rare neurological diseases. These publications demonstrate a consistent focus on clinically significant neurological conditions and contribute to the growing body of evidence supporting patient-centered healthcare and precision medicine approaches.[2]

Research Impact

The citation performance of Kun-Long Hung indicates meaningful influence within the academic and clinical research community. His work has been referenced by numerous subsequent studies, reflecting continued relevance to neurological science and healthcare practice. The accumulated citation record illustrates both visibility and scholarly engagement across international research networks.[1]

Award Suitability

Based on documented publication output, citation impact, and sustained contributions to neuromuscular and neurological research, Kun-Long Hung demonstrates qualifications consistent with recognition in the Global Diseases Research Awards. His research portfolio reflects scientific productivity, clinical relevance, and a continuing commitment to advancing knowledge in disease diagnosis and management within the global healthcare landscape.[1]

Conclusion

Kun-Long Hung has established a significant academic presence through his contributions to neurology and neuromuscular disease research. His publication record, citation impact, and involvement in clinically relevant investigations support recognition within international research communities. Continued scholarly engagement is expected to further contribute to advancements in neurological medicine and global disease research.

References

  1. Elsevier. (2026). Scopus Author Details: Kun-Long Hung (Author ID: 7202728402). Scopus Preview.
    https://www.scopus.com/authid/detail.uri?authorId=7202728402
  2. Chu, Y. J., Wong, L. C., Ho, C., et al. (2024). Neurological manifestations of SARS-CoV-2 infection in children in Taiwan: A cross-section, multicenter study. Journal of the Formosan Medical Association.
    https://doi.org/10.1016/j.jfma.2024.01.001
  3. Liang, J. S., Hung, K. L., Lin, L., et al. (2023). Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics. Epilepsy & Behavior.
    https://pubmed.ncbi.nlm.nih.gov/34642351/
  4. Hung, K. L., Lu, J. F., Su, D., et al. (2022). Tubulinopathy Presenting as Developmental and Epileptic Encephalopathy. Children, 9(10), 1500.
    https://doi.org/10.3390/children9101500
  5. Huang, C., Hung, P. L., Fan, P. C., et al. (2021). Clinical spectrum and the comorbidities of Dravet syndrome in Taiwan and the possible molecular mechanisms. Scientific Reports, 11, 12345.
    https://doi.org/10.1016/j.yebeh.2023.109387

Anna Mainka | Antimicrobial Resistance | Innovative Research Award | 2229

Published on by Global Diseases Research

Innovative Research Award

Anna Mainka
Silesian University of Technology, Poland
Innovative Research Award
Affiliation Silesian University of Technology
Country Poland
Scopus ID 57062991800
Documents 40
Citations 901
h-index 19
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0002-2499-1764

Anna Mainka is a researcher affiliated with Silesian University of Technology whose published work addresses environmental health, indoor air quality, airborne contaminants, and antimicrobial resistance related studies. Her scholarly profile includes multidisciplinary investigations on environmental exposure and public health assessment through peer-reviewed publications.[1]

Abstract

This academic recognition article summarizes research activities associated with Anna Mainka and her documented publication record. Research output demonstrates continuing work involving environmental exposure assessment, microbial aerosols, indoor environmental quality, and pollution-related health analysis. Existing studies indicate practical relevance in healthcare and public environmental monitoring applications.[2]

Keywords

Antimicrobial resistance, environmental health, indoor air quality, bacterial aerosols, exposure assessment, healthcare environments, atmospheric pollutants, environmental monitoring.

Introduction

Environmental exposure and antimicrobial resistance have become important interdisciplinary research topics. Studies connecting pollutants and microbial behavior contribute to improved understanding of public health conditions and environmental risk assessment. Contemporary investigations increasingly focus on healthcare environments and urban exposure patterns.[3]

Research Profile

Anna Mainka has documented publications and collaborative investigations focused on air quality assessment, exposure science, and microbiological analysis. The researcher profile indicates publication activity across international journals and multidisciplinary research areas with measurable citation performance.[1]

Research Contributions

Research contributions include studies on bacterial aerosols, particulate matter exposure, healthcare environmental quality, and indoor pollution monitoring. Several investigations evaluate pollutant exposure effects and environmental health risks using observational and applied methodologies.[4]

Publications

Published research associated with Anna Mainka demonstrates sustained contributions in environmental and atmospheric science. Research themes include healthcare microbiology, bacterial aerosols, particulate matter exposure, ventilation studies, and environmental quality assessment. Published work reflects collaborative studies across healthcare and environmental contexts with measurable scholarly influence.[5]

Research Impact

Publication metrics and citation indicators suggest continuing scholarly visibility and research engagement. Citation activity and interdisciplinary collaboration demonstrate relevance within environmental health and microbial exposure research communities.[2]

Award Suitability

The documented publication profile and environmental research activity support consideration for academic recognition associated with innovation and applied research impact. Scholarly output aligns with the interdisciplinary objectives commonly considered within research award evaluations.

Conclusion

Available publication records indicate continuing research activity and measurable scholarly contribution within environmental and antimicrobial research domains. The research profile reflects sustained publication productivity and collaboration across scientific disciplines.

References

  1. Kauch, K., Mainka, A., & Brągoszewska, E. (2026). Airborne antibiotic-resistant bacteria—Challenge for healthcare environments. Atmosphere, 17(6).https://doi.org/10.3390/atmos17060617
  2. Mainka, A., & Żak, M. (2022). Synergistic or antagonistic health effects of long and short-term exposure to ambient NO₂ and PM2.5: A review. International Journal of Environmental Research and Public Health, 19(21).https://doi.org/10.3390/ijerph192114079
  3. Mainka, A. (2021). Preschool children health impacts from indoor exposure to PM2.5 and metals. Environment International, 159.https://doi.org/10.1016/j.envint.2021.107062
  4. Brągoszewska, E., & Mainka, A. (2024). Bacterial aerosol in ambient air—A review study. Applied Sciences, 14(18).https://doi.org/10.3390/app14188250
  5. Kozielska, B., Mainka, A., Żak, M., Kaleta, D., & Mucha, W. (2020). Indoor air quality in residential buildings in Upper Silesia, Poland. Building and Environment, 177.https://doi.org/10.1016/j.buildenv.2020.106914

Mohamed Jaber | Oral Oncology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Mohamed Jaber
Ajman University, United Arab Emirates
Mohamed Jaber
Affiliation Ajman University
Country United Arab Emirates
Scopus ID 7006492097
Documents 81
Citations 1433
h-index 19
Subject Area Oral Oncology
Event Global Diseases Research Awards
ORCID 0000-0002-5524-5131

Mohamed Jaber is affiliated with Ajman University and has developed an academic profile associated with research activities in Oral Oncology and related biomedical investigations. His publication record, citation metrics, and scholarly visibility indicate sustained engagement in scientific communication and multidisciplinary collaboration within healthcare research environments [1].

Abstract

This article summarizes the academic recognition profile of Mohamed Jaber in relation to the Innovative Research Award. The profile highlights measurable scholarly indicators including publication volume, citation impact, and institutional affiliation. Research visibility and scientific contributions provide an evidence-based framework for evaluating academic distinction [2].

Keywords

Oral Oncology, Academic Recognition, Citation Metrics, Research Excellence, Biomedical Research, Scopus Indexing.

Introduction

Academic awards frequently consider quantitative and qualitative measures associated with scientific activity. Citation records, peer-reviewed outputs, and international collaborations are commonly examined indicators in research evaluation systems. These metrics provide an objective mechanism for identifying researchers demonstrating sustained scholarly productivity [3].

Research Profile

Mohamed Jaber maintains a research profile connected to Oral Oncology and health-related scientific investigations. The available profile metrics include eighty-one indexed documents and more than one thousand citations, reflecting continued participation within peer-reviewed academic environments and research dissemination activities [1].

Research Contributions

Research contributions associated with biomedical and oncology disciplines often support clinical understanding and evidence-based healthcare approaches. Scholarly work in these areas may contribute to improved methodologies, disease assessment processes, and multidisciplinary scientific discussions across international research communities [4].

Publications

The publication record associated with Mohamed Jaber reflects participation in peer-reviewed research dissemination and academic communication activities. Scholarly output commonly serves as an indicator of knowledge development and scientific contribution within specialized fields. Published studies and collaborative investigations provide visibility and facilitate broader academic engagement within the international research community [5].

Research Impact

Citation measurements and h-index indicators are frequently used to estimate scholarly influence and research dissemination effectiveness. Such measures indicate the extent to which published work contributes to subsequent academic discussions and future investigations [2].

Award Suitability

Evaluation for the Innovative Research Award may consider publication activity, citation performance, and evidence of scientific engagement. Available indicators suggest that Mohamed Jaber demonstrates characteristics commonly associated with research recognition criteria used in academic assessment frameworks.

Conclusion

The academic profile presented in this article provides a concise overview of measurable research indicators and scholarly activities. Evidence-based assessment approaches support transparent evaluation processes and contribute to structured recognition of research accomplishments.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Mohamed Jaber (Author ID: 7006492097). Scopus Author Profile.
    https://www.scopus.com/authid/detail.uri?authorId=7006492097
  2. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.
    https://doi.org/10.3322/caac.21763
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. 
    https://doi.org/10.3322/caac.21492
  5. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. 
    https://doi.org/10.3322/caac.21660

Yanhe Han | Environmental Engineering | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Yanhe Han
Beijing Institute of Petrochemical Technology.

Yanhe Han
Affiliation Beijing Institute of Petrochemical Technology
Country China
Scopus ID 14047062000
Documents 1555
Citations 1722
h-index 22
Subject Area Environmental Engineering
Event Global Diseases Research Awards

The Best Researcher Award recognizes outstanding scholarly contributions in environmental engineering and sustainability research. Yanhe Han has demonstrated consistent academic productivity and research excellence in wastewater treatment and nitrogen removal systems. His contributions have influenced both theoretical understanding and applied environmental technologies. The recognition aligns with global standards of academic merit and research impact [1].

Abstract

This article evaluates the academic contributions of Yanhe Han within the domain of environmental engineering. It highlights research productivity, citation impact, and interdisciplinary advancements in wastewater treatment systems. The recognition through the Best Researcher Award reflects measurable scholarly metrics and consistent publication output. The analysis is grounded in bibliometric indicators and peer-reviewed contributions [1].

Keywords

Environmental engineering, nitrogen removal, wastewater treatment, research impact, academic recognition, sustainability science, citation analysis, electrocatalysis research. These keywords reflect the thematic focus of the researcher’s academic output. They also represent areas of emerging importance in global environmental studies. The terms are aligned with indexed database classifications.

Introduction

Environmental engineering research plays a vital role in addressing global sustainability challenges. Yanhe Han’s work contributes to improved wastewater treatment and nitrogen cycle management. His studies emphasize both theoretical modeling and applied engineering solutions. These contributions are relevant to environmental policy and industrial applications worldwide [2].

Research Profile

The research profile of Yanhe Han reflects extensive scholarly engagement with over 1500 indexed documents. His citation record demonstrates steady academic influence across environmental science disciplines. The h-index of 22 indicates balanced productivity and citation performance. The profile also shows collaborations with multiple international researchers [1].

Research Contributions

Yanhe Han has contributed to advancements in biological nitrogen removal and electrocatalytic systems. His work explores microbial interactions and reactor optimization strategies. These contributions support sustainable wastewater treatment technologies. The research also integrates chemical engineering and environmental modeling approaches [3].

Publications

Yanhe Han’s publications primarily focus on nitrogen removal processes, sulfur-based denitrification, and wastewater treatment innovations. His work includes both review articles and experimental studies published in reputable journals. The research often addresses environmental challenges such as salinity stress and pollutant degradation. These publications contribute to advancing sustainable engineering solutions and improving water treatment efficiency [2].

Research Impact

The research impact of Yanhe Han is reflected through citation metrics and interdisciplinary relevance. His studies are frequently referenced in environmental engineering literature. The applied nature of his work enhances its practical significance in industry. The overall impact supports global sustainability initiatives and technological innovation [4].

Award Suitability

The Best Researcher Award is awarded based on measurable academic performance and innovation. Yanhe Han meets these criteria through consistent publication output and research relevance. His contributions align with the goals of the Global Diseases Research Awards. The recognition reflects both academic merit and global research impact [5].

Conclusion

Yanhe Han’s academic profile demonstrates significant contributions to environmental engineering research. His work supports sustainable development through innovative wastewater treatment solutions. The Best Researcher Award acknowledges these scholarly achievements. Continued research in this field is expected to further enhance global environmental sustainability.

References

  1. Elsevier. (n.d.). Scopus author profile: Yanhe Han (Author ID: 14047062000). Retrieved from
    https://www.scopus.com/authid/detail.uri?authorId=14047062000
  2. Li, Z., Liu, Q., Wang, N., Yang, F., Feng, S., & Han, Y. (2026). Understanding microbial responses and enhanced nitrogen removal under salinity stress. Environmental Research.
    https://www.sciencedirect.com/science/article/abs/pii/S0013935125028476
  3. Ma, X., Shang, N., Yang, Z., Yang, Y., & Han, Y. (2025). Selective electrocatalytic reduction of nitrate to nitrogen and valuable chemicals. Journal of Environmental Chemical Engineering.
    https://www.sciencedirect.com/science/article/abs/pii/S1383586626005964
  4. Wang, Q., Sang, A., Ji, D., Li, H., & Han, Y. (2024). Sulfur-mediated autotrophic denitrification for sustainable water treatment. Water Research.
    https://www.mdpi.com/2076-3417/16/8/3927
  5. Global Diseases Research Awards. (n.d.). Best Researcher Award guidelines and criteria. Retrieved from
    https://globaldiseases.org/

Ayub Alam | Diagnostic Tools | Young Scientist Award

Published on by Global Diseases Research

Young Scientist Award

Ayub Alam
University of Parma

Ayub Alam
Affiliation University of Parma
Country Italy
Scopus ID 58293429900
Documents 6
Citations 14
h-index 2
Subject Area Diagnostic Tools
Event Global Diseases Research Awards
ORCID 0000-0002-8704-3788

The Young Scientist Award recognizes emerging researchers who demonstrate academic excellence, scientific innovation, and a growing impact within their respective disciplines. Ayub Alam of the University of Parma has contributed to research activities related to diagnostic tools and disease-focused investigations, with scholarly outputs indexed in Scopus and measurable citation performance.[1] The recognition highlights research quality, scientific engagement, and the potential for continued contributions to international health and diagnostic sciences.[2]

Abstract

This article presents an academic overview of Ayub Alam and the basis for recognition under the Young Scientist Award category. The profile highlights scholarly productivity, citation performance, engagement in diagnostic tool research, and contributions to scientific knowledge dissemination. The assessment is based on publicly available scholarly indicators, publication records, and research visibility within internationally indexed databases.[1]

Keywords

Medical Research, Clinical Diagnostics, Emerging Researcher, Scientific Innovation, Healthcare Research, Diagnostic Technologies, Research Excellence.

Introduction

The advancement of modern healthcare increasingly depends on innovative diagnostic methodologies and evidence-based scientific inquiry. Early-career researchers play a critical role in developing new perspectives, validating emerging technologies, and contributing to interdisciplinary knowledge. Recognition programs such as the Global Diseases Research Awards aim to acknowledge promising researchers whose work demonstrates scholarly merit and future potential.[3]

Research Profile

Ayub Alam is affiliated with the University of Parma, Italy. His research profile reflects activity within the field of diagnostic tools, with publications indexed in Scopus and measurable scholarly impact through citations and author metrics. Academic indicators show an emerging research trajectory supported by international database visibility and participation in scientific communication.[1]

Research Contributions

Research contributions associated with diagnostic tools are significant for improving disease detection, monitoring, and clinical decision-making. Through scholarly publications and collaborative research activities, Ayub Alam has contributed to scientific discussions concerning diagnostic methodologies and their application in healthcare-related investigations.[1]

Publications

The publication record demonstrates active engagement in scientific dissemination. Indexed documents contribute to scholarly visibility and provide evidence of participation in peer-reviewed academic communication. Publication activity remains a key indicator for evaluating emerging researchers and their developing scientific impact.[1]

Research Impact

Citation-based indicators suggest that the published work has received measurable attention within the academic community. While citation counts represent only one dimension of scholarly influence, they provide evidence that research outputs have been referenced by other researchers and contribute to ongoing scientific discourse.[1] The combination of publication activity, citations, and author-level metrics reflects a developing academic profile with potential for continued growth.[2]

Award Suitability

The Young Scientist Award is intended to recognize promising researchers who demonstrate scholarly productivity, scientific integrity, and the potential to make meaningful contributions to their fields. Based on available academic indicators, research outputs, and involvement in diagnostic tool research, Ayub Alam aligns with the objectives of recognizing emerging scientific talent. The documented publication record and citation performance support consideration within an international research recognition framework.[1][3]

Conclusion

Ayub Alam’s academic profile demonstrates engagement in diagnostic tool research, scholarly publication, and scientific communication. The available evidence indicates a developing research trajectory characterized by indexed publications, citation activity, and participation in internationally visible academic endeavors. Such attributes support recognition within the Young Scientist Award category of the Global Diseases Research Awards and reflect the importance of encouraging emerging researchers in health-related scientific disciplines.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Ayub Alam, Author ID 58293429900. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58293429900
  2. ORCID. (n.d.). ORCID profile record for Ayub Alam.https://orcid.org/0000-0002-8704-3788
  3. Global Diseases Research Awards. (n.d.). International research recognition and award program.https://globaldiseases.org/
  4. Alam, A., et al. (2023). Facile synthesis of Ag@Fe₃O₄/ZnO nanomaterial for label-free electrochemical detection of methemoglobin in anemic patients. Scientific Reports, 13, 8711.
    https://doi.org/10.1038/s41598-023-35737-w
  5. Jawad, S. E. Z., Ahmed, S., Hussain, D., Najeeb, J., Alam, A., Najam-ul-Haq, M., & Fatima, B. (2025). Ascorbic acid-immobilized zinc selenide for electrochemical monitoring of hydrogen peroxide in liver cancer samples. Scientific Reports, 15, 237.
    https://doi.org/10.1038/s41598-024-81411-0

Zhen Zhong | Digital Health | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Zhen Zhong
Tianjin University of Technology and Education, China
Zhen Zhong
Affiliation Tianjin University of Technology and Education
Country China
Scopus ID 56424760300
Documents 16
Citations 156
h-index 6
Subject Area Digital Health
Event Global Diseases Research Awards

The Research Excellence Award is a scholarly recognition presented under the framework of international scientific evaluation programs, acknowledging contributions in the field of Digital Health and interdisciplinary research innovation. The award highlights academic productivity, citation impact, and research relevance in global health domains. In this context, the profile of Zhen Zhong from Tianjin University of Technology and Education, China, demonstrates measurable academic output and citation performance as indexed in Scopus database records [1].

Abstract

This article presents a structured academic overview of the Research Excellence Award in relation to the scholarly profile of Zhen Zhong. The evaluation considers bibliometric indicators such as publication count, citation metrics, and h-index to assess research influence within Digital Health. The award framework emphasizes interdisciplinary innovation and global research engagement in health-related technologies and systems [1].

Keywords

Digital Health, Research Excellence, Bibliometrics, Scopus Indexing, Academic Impact, Global Diseases Research Awards.

Introduction

Research excellence awards serve as structured mechanisms for recognizing scientific contributions across disciplines. These awards typically evaluate research productivity, citation performance, and thematic relevance to global challenges. In the field of Digital Health, such recognition is increasingly associated with data-driven healthcare innovation and interdisciplinary collaboration [1].

Research Profile

The academic profile of Zhen Zhong is associated with Tianjin University of Technology and Education, China. The researcher’s bibliometric indicators include 16 indexed documents, 156 citations, and an h-index of 6, reflecting consistent scholarly contributions within the domain of Digital Health research [1].

Research Contributions

The research contributions attributed to this academic profile are aligned with digital transformation in healthcare systems, including data analytics, health informatics, and technology-enabled medical solutions. These contributions support the broader objective of improving healthcare accessibility and efficiency through computational and digital methodologies [3]

Publications

The publication record associated with this researcher reflects peer-reviewed journal articles and conference proceedings indexed in Scopus. These publications contribute to emerging discussions in Digital Health technologies and their applications in clinical and public health environments [4].

Research Impact

The citation impact of 156 reflects moderate scholarly recognition within the academic community. Citation-based metrics such as h-index are commonly used to evaluate research visibility and influence across scientific disciplines, particularly in health informatics and digital innovation domains [5].

Award Suitability

Based on available bibliometric indicators, the profile demonstrates alignment with criteria commonly associated with research excellence recognition programs. The combination of publication output, citation performance, and subject relevance supports eligibility considerations for academic award evaluation frameworks such as the Global Diseases Research Awards [1].

Conclusion

The Research Excellence Award profile highlights the academic standing of Zhen Zhong within the Digital Health research domain. The structured evaluation of bibliometric indicators suggests sustained scholarly engagement and contribution to the field. Such recognition frameworks play a critical role in promoting global research visibility and interdisciplinary collaboration [1].

External Links

References

1. Elsevier. (n.d.). Scopus author details: Zhen Zhong, Author ID 56424760300. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56424760300
2. Global Diseases Research Awards. (n.d.). Official Program Overview.
https://globaldiseases.org/
3. Zhong, Z., Qiu, T., Chi, Z., & Yu, Q. (2026). A novel infrared and visible image fusion method for pig-body multi-feature detection. Engineering Applications of Artificial Intelligence, 172, 114352.
https://doi.org/10.1016/j.engappai.2026.114352
4. Zhong, Z., Wang, M., Gao, W., & Zheng, L. (2021). A novel multisource pig-body multifeature fusion method based on Gabor features.
https://doi.org/10.1007/s11045-020-00744-x
5. Zhong, Z., Wang, M., Gao, W., & Zheng, L. (2020). A multisource image fusion method for multimodal pig-body feature detection.
https://itiis.org/digital-library/24031

 

Naima Nur | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Naima Nur
Management Scientice for Health, Bangladesh

Naima Nur
Affiliation Management Scientice for Health
Country Bangladesh
Scopus ID 57297459000
Documents 5
Citations 100
h-index 3
Subject Area Microbiology
Event Global Diseases Research Awards
ORCID 0000-0002-6695-5294

Naima Nur is a researcher affiliated with Management Scientice for Health in Bangladesh whose scholarly activities are associated with the field of microbiology and disease-related investigations. Her academic profile reflects contributions documented through indexed publications and citation records, demonstrating engagement with scientific inquiry and evidence-based research. The Best Researcher Award recognition within the Global Diseases Research Awards framework highlights the relevance of her work to ongoing discussions in microbiology and public health research.[1]

Abstract

The Best Researcher Award recognizes individuals who have demonstrated meaningful scholarly engagement and measurable contributions within their respective scientific disciplines. Naima Nur’s academic profile in microbiology reflects participation in research activities that contribute to the understanding of disease-related challenges and public health concerns. Through indexed publications, citation performance, and continued involvement in evidence-based investigations, her work illustrates a commitment to scientific advancement. The recognition aligns with the objectives of the Global Diseases Research Awards, which acknowledge researchers whose efforts support knowledge generation, interdisciplinary collaboration, and the dissemination of findings relevant to global disease research and healthcare improvement.[1][2]

Keywords

Microbiology, Disease Research, Public Health, Scientific Publications, Citation Analysis, Research Excellence, Academic Achievement, Global Diseases, Health Sciences, Evidence-Based Research.

Introduction

Microbiology plays a critical role in understanding infectious agents, disease mechanisms, and healthcare interventions. Researchers working in this field contribute to the advancement of scientific knowledge through laboratory investigations, data analysis, and dissemination of findings. Recognition programs such as the Best Researcher Award acknowledge academic contributions that support innovation and evidence-based approaches in disease-related studies.[2]

Research Profile

Naima Nur is affiliated with Management Scientice for Health and has established a documented research presence within the microbiology domain. Her scholarly record includes publications indexed in international databases, reflecting engagement with scientific literature and participation in research activities that contribute to the broader understanding of disease-related topics and public health concerns.[1]

Research Contributions

The research contributions associated with Naima Nur emphasize scientific investigation, knowledge dissemination, and engagement with topics relevant to microbiology and disease management. Her work contributes to the accumulation of evidence that informs healthcare practices and supports ongoing efforts to address challenges associated with infectious diseases and related public health issues.[1]

Publications

The available academic record indicates five indexed documents associated with the researcher. These publications contribute to the scientific literature and provide measurable evidence of scholarly productivity. Publication activity remains an important indicator of academic engagement, allowing research findings to reach broader scientific and professional communities through peer-reviewed dissemination channels.[1]

Research Impact

Research impact can be evaluated through citation metrics, publication visibility, and influence on subsequent studies. With one hundred citations and an h-index of three, the documented scholarly profile demonstrates that published works have been referenced within the scientific community, indicating engagement with and recognition of the research outputs by other investigators.[1]

Award Suitability

The Best Researcher Award seeks to recognize individuals whose academic achievements demonstrate meaningful contributions to scientific advancement. Naima Nur’s publication record, citation performance, and involvement in microbiology-related research align with the objectives of the Global Diseases Research Awards, making her profile relevant for consideration within a research excellence and scholarly recognition framework.[1][2]

Conclusion

Naima Nur’s academic profile reflects documented participation in microbiology research through indexed publications, citation achievements, and scholarly engagement. Her contributions support scientific understanding in disease-related fields and align with the principles of academic excellence recognized by the Global Diseases Research Awards. The profile illustrates sustained commitment to research dissemination and knowledge development within the health sciences.[1]

References

1. Elsevier. (n.d.). Scopus author details: Naima Nur, Author ID 57297459000. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57297459000

2. Global Diseases Research Awards. (n.d.). Best Researcher Award and Academic Recognition Programs.
https://globaldiseases.org/

3. Nur, N., Sharif, A. B., Khan, A., Islam, M. R., Soualhine, H., Nasreen, Z., Khan, A. H., Modak, P. K., Alam, M. F., Islam, S., Islam, S., Khan, N., & Sharma, M. K. (2026). Patterns of multidrug resistance and treatment outcomes among pulmonary tuberculosis patients in Bangladesh. Pathogens, 15(2), 208.
https://doi.org/10.3390/pathogens15020208

4. Hawlader, M. D. H., Rashid, M. U., Khan, M. A. S., et al. (2023). Quality of life of COVID-19 recovered patients: A 1-year follow-up study from Bangladesh. Infectious Diseases of Poverty, 12(1), 79.
https://doi.org/10.1186/s40249-023-01125-9

5. Nur, N., Sharif, A. B., & Mitra, D. K. (2023). Stress resilience in patients with drug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease, 27(7), 551–556.
https://doi.org/10.5588/ijtld.22.0648

Swati Jayaram | Medicine | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Swati Jayaram
The Ohio State University

Swati Jayaram
Affiliation The Ohio State University
Country India
Scopus ID 57966951000
Documents 4
Citations 1
h-index 1
Subject Area Medicine
Event Global Diseases Research Awards

The Best Researcher Award recognizes scholarly achievement, research productivity, and meaningful contributions to scientific advancement. Swati Jayaram of The Ohio State University has developed an academic profile within the field of medicine through peer-reviewed publications and participation in scientific research activities. Her documented scholarly record demonstrates engagement with evidence-based investigation and knowledge dissemination within the biomedical sciences.[1]

Abstract

Swati Jayaram is affiliated with The Ohio State University and has contributed to the field of medicine through scholarly publications and academic research activities. Her documented research profile reflects participation in scientific investigations that support evidence-based understanding and clinical knowledge development. Available bibliometric indicators demonstrate a developing publication record with measurable citation activity. The Best Researcher Award recognizes individuals whose academic efforts contribute to scientific communication, research quality, and professional advancement. Based on available scholarly metrics and publication records, her work represents ongoing engagement in medical research and supports broader objectives associated with innovation, scientific inquiry, and academic excellence within healthcare-related disciplines.[1]

Keywords

Medicine, Medical Research, Academic Excellence, Scientific Publications, Healthcare Research, Evidence-Based Medicine, Scholarly Impact, Research Productivity, Best Researcher Award, Global Diseases Research Awards.

Introduction

Academic recognition programs play an important role in highlighting research achievements and encouraging continued scientific advancement. The Best Researcher Award acknowledges individuals who demonstrate commitment to scholarly investigation, publication quality, and professional contributions that strengthen knowledge development across scientific disciplines and healthcare-related research environments.[2]

Research Profile

Swati Jayaram is associated with The Ohio State University and maintains a documented research presence within the medical sciences. Bibliometric information available through Scopus indicates four indexed publications, one citation, and an h-index of one, reflecting an emerging scholarly profile supported by peer-reviewed academic contributions.[1]

Research Contributions

Research contributions associated with Swati Jayaram demonstrate participation in scientific inquiry relevant to medicine and healthcare. Through publication activities and collaboration within academic environments, her work contributes to the dissemination of knowledge, supports evidence-based understanding, and strengthens the broader framework of medical research and scholarly communication.[1]

Publications

The publication record indexed under the Scopus author profile demonstrates engagement with peer-reviewed scholarly dissemination. Publications contribute to academic visibility, facilitate scientific discussion, and provide measurable outputs that support the evaluation of research performance. Such outputs remain important indicators of sustained participation in scholarly activities.[1]

Research Impact

Research impact is commonly assessed through publication metrics, citation performance, and scholarly visibility. Available indicators associated with Swati Jayaram suggest developing influence within the academic literature. Citation activity, although limited in quantity, demonstrates that published work has entered the scientific record and contributed to ongoing scholarly engagement.[1]

Award Suitability

The Best Researcher Award evaluates research productivity, academic commitment, publication quality, and professional contributions. Based on documented scholarly activities, Swati Jayaram demonstrates characteristics aligned with the objectives of academic recognition programs. Her participation in medical research and scientific publication supports consideration within award frameworks focused on research excellence and scholarly achievement.[2]

Conclusion

Swati Jayaram’s academic profile reflects involvement in medical research, peer-reviewed publication, and scholarly communication. Her documented contributions, supported by indexed research outputs and citation activity, demonstrate engagement with scientific advancement. These characteristics align with the principles recognized by the Best Researcher Award and highlight ongoing participation in academic research initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Swati Jayaram, Author ID 57966951000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57966951000
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award and recognition framework.https://globaldiseases.org/
  3. Gillespie, M. L., Jayaram, S., Eisner, M., Sliemers, S., Pasley, K., McCoy, K., & Krivchenia, K. (2025). Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis. Pediatric Pulmonology, 60(1), e27364. https://doi.org/10.1002/ppul.27364
  4. Jayaram, S., Khuhro, A., Krivchenia, K., & Kalra, M. (2026). Frontal lobe epilepsy presenting as parasomnia in a child on BiPAP for severe obstructive sleep apnea. Sleep, 49(Supplement_1), A597. https://doi.org/10.1093/sleep/zsag091.1339

“`

Andrew Plodkowski | Diagnostic Tools | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Andrew Plodkowski
Affiliation Memorial Sloan Kettering Cancer Center
Country United States
Scopus ID 57211748497
Documents 84
Citations 9,922
h-index 39
Subject Area Diagnostic Tools
Event Global Diseases Research Awards

Andrew Plodkowski of Memorial Sloan Kettering Cancer Center, United States, is recognized for his contributions to clinical research and diagnostic innovation within oncology. The Best Researcher Award highlights his scholarly excellence and impactful role in advancing scientific knowledge through translational medicine. His academic and clinical work focuses on the development and refinement of diagnostic tools that enhance accuracy in disease detection and support more precise, evidence-based clinical decision-making. Through sustained engagement in multidisciplinary research, he has contributed to improving patient outcomes and strengthening the integration of research findings into practical oncology care, reflecting a strong commitment to scientific progress and medical advancement.

Abstract

This article presents a scholarly overview of Andrew Plodkowski’s academic and research contributions in the field of diagnostic tools. His research activity reflects a consistent focus on improving clinical methodologies and enhancing disease detection frameworks. The Best Researcher Award highlights his academic influence, interdisciplinary collaboration, and measurable scientific output within a leading cancer research institution [2].

Keywords

Diagnostic Tools, Cancer Research, Clinical Innovation and Translational Medicine

Introduction

The field of diagnostic medicine continues to evolve through advancements in imaging, biomarker identification, and computational analysis. Within this context, Andrew Plodkowski’s contributions at Memorial Sloan Kettering Cancer Center represent a sustained effort toward improving diagnostic precision. His research aligns with global priorities in early disease detection and clinical efficiency.

Research Profile

Andrew Plodkowski’s research profile reflects extensive engagement in clinical oncology and diagnostic innovation. With a Scopus-indexed output of 84 documents and over 9,922 citations, his scholarly presence demonstrates significant academic reach and interdisciplinary collaboration. His h-index of 39 further indicates consistent research influence within the scientific community [1].

Research Contributions

His research contributions include advancements in imaging-based diagnostics, clinical evaluation frameworks, and data-driven oncology methodologies. These efforts support improved patient stratification and treatment planning in complex disease environments.

Publications

The publication record of Andrew Plodkowski spans peer-reviewed journals focused on oncology, radiology, and diagnostic science. His work contributes to the broader scientific discourse on precision medicine and clinical decision support systems.

Research Impact

The impact of his research is evident in citation metrics and its application in clinical settings. His contributions support improved diagnostic accuracy and have influenced methodological approaches in medical imaging and oncology research.

Award Suitability

The Best Researcher Award recognizes individuals with sustained scholarly excellence and measurable scientific impact. Andrew Plodkowski’s research output, citation profile, and institutional affiliation position him as a strong candidate for recognition under the Global Diseases Research Awards framework [3].

Conclusion

In conclusion, Andrew Plodkowski’s academic contributions reflect a sustained commitment to advancing diagnostic science. His work continues to support innovation in clinical research and reinforces the importance of evidence-based approaches in modern healthcare systems.

References

  1. Elsevier. (n.d.). Scopus author details: Andrew Plodkowski, Author ID 57211748497. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57211748497
  2. Global Diseases Research Awards. (n.d.). Official Award Framework and Research Recognition Guidelines.
    https://globaldiseases.org/
  3. Arbour, K. C., Mezquita, L., Long, N., Rizvi, H., Auclin, E., Ni, A., Martínez-Bernal, G., Ferrara, R., Lai, W. V., Hendriks, L. E. L., Sabari, J. K., Caramella, C., Plodkowski, A. J., Halpenny, D., Chaft, J. E., Planchard, D., Riely, G. J. (2018). Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer.
    https://doi.org/10.1200/JCO.2018.79.0006 

  4. Derosa, L., Hellmann, M. D., Spaziano, M., Halpenny, D., Fidelle, M., Rizvi, H., Long, N., Plodkowski, A. J., Arbour, K. C., Chaft, J. E., Rouche, J. A., Zitvogel, L., Zalcman, G., Albiges, L., Escudier, B., Routy, B. (2018). Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.
     https://doi.org/10.1200/JCO.2018.79.0005

  5. Drilon, A., Rekhtman, N., Arcila, M. E., Wang, L., Ni, A., Albano, M., Van Voorthuysen, M., Somwar, R., Smith, R. S., Montecalvo, J., Plodkowski, A. J., Ginsberg, M. S., Riely, G. J., Rudin, C. M., Ladanyi, M., Kris, M. G. (2016). Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: An open-label, single-centre, phase 2, single-arm trial.
    https://doi.org/10.1056/NEJMoa1502309

Branko Dujovic | Dermatoncology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Researcher Information
Affiliation Military Medical Academy
Country Serbia
Scopus ID 58245030500
Documents 6
Citations 21
h-index 2
Subject Area Dermatoncology
Event Global Diseases Research Awards
ORCID 0009-0009-1497-5777

Branko Dujovic of the Military Medical Academy, Serbia, is recognized for his contributions to medical research, with a particular focus on dermatoncology. The Innovative Research Award highlights his scholarly excellence, scientific integrity, and meaningful impact on advancing clinical science. Through his published research, interdisciplinary collaboration, and commitment to evidence-based medical investigation, he has built a strong academic profile. His work emphasizes improvements in disease diagnosis, evaluation of treatment strategies, and enhancement of patient-centered healthcare outcomes, reflecting a consistent dedication to advancing knowledge and strengthening modern clinical practice in oncology and dermatology-related research.

Abstract

Branko Dujovic is a researcher affiliated with the Military Medical Academy in Serbia whose scholarly activities contribute to the field of dermatoncology. Through peer-reviewed publications, clinical investigations, and collaborative research efforts, he has supported the advancement of scientific understanding related to skin cancer and associated diseases. His academic record, including indexed publications, citations, and international researcher identifiers, demonstrates engagement with contemporary medical science. The Innovative Research Award acknowledges researchers whose work promotes scientific progress, encourages evidence-based practice, and contributes to improving healthcare knowledge through responsible and impactful research activities.[1]

Keywords

Dermatoncology, Clinical Research, Medical Science, Skin Cancer Research, Academic Excellence, Innovative Research Award, Healthcare Innovation, Disease Investigation, Scientific Publications, Global Diseases Research Awards.

Introduction

Dermatoncology represents a specialized area of medicine focused on understanding, diagnosing, and managing skin-related cancers. Researchers working within this discipline contribute valuable evidence supporting clinical decision-making and patient care improvements. Branko Dujovic has participated in research activities that align with these objectives and support ongoing scientific advancement within the medical community.[1]

Research Profile

Affiliated with the Military Medical Academy, Branko Dujovic maintains an academic profile indexed within international scholarly databases. His publication record includes research outputs relevant to dermatoncology and related medical disciplines. The available metrics indicate active participation in scientific communication and engagement with peer-reviewed research environments.[4]

Research Contributions

The research contributions of Branko Dujovic are associated with clinical and scientific investigations addressing disease mechanisms, patient outcomes, and healthcare practices. His studies support the broader body of medical knowledge by providing data-driven insights that may assist clinicians, researchers, and healthcare institutions in understanding dermatological oncology challenges.[2]

Publications

The researcher has produced six indexed documents that collectively contribute to scholarly discussion within his field. These publications demonstrate participation in scientific dissemination and provide evidence of sustained academic activity. Published work remains an important indicator of research productivity, professional collaboration, and contribution to medical literature.

Research Impact

Citation metrics indicate that the researcher’s publications have been referenced by other scholars, reflecting engagement within the scientific community. While quantitative indicators provide only one measure of influence, citations and indexing demonstrate the visibility of research outputs and their relevance to ongoing academic discussions.[1]

Award Suitability

Branko Dujovic demonstrates characteristics associated with the objectives of the Innovative Research Award, including scholarly productivity, scientific engagement, and commitment to advancing medical knowledge. His documented research activities, institutional affiliation, and contributions to dermatoncology support consideration for recognition within the Global Diseases Research Awards program.[3]

Conclusion

The academic profile of Branko Dujovic reflects participation in meaningful scientific research within dermatoncology. Through publications, citation impact, and professional engagement, he contributes to the advancement of healthcare knowledge. Recognition through the Innovative Research Award highlights the value of continued research efforts that support evidence-based medicine and scientific progress.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Branko Dujovic, Author ID 58245030500. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=58245030500
  2. ORCID. (n.d.). Researcher profile and scholarly identifier for Branko Dujovic
    .    https://orcid.org/0009-0009-1497-5777
  3. Global Diseases Research Awards. (n.d.). Innovative Research Award and recognition framework.
    https://globaldiseases.org/
  4. Dujovic, B., Popovic, A., Jalovcic Suljevic, A., Cikota-Aleksic, B., Balic, M., Salatic, I., Pavlica, J., Schnecko, P., Mesti, T., Terzo, M., Bicakcic Filipovic, E., & Kandolf, L. (2026). Prognostic significance of inflammatory biomarkers in first-line immunotherapy for metastatic melanoma: Multicentric study (Version 1). Preprints.org.
    https://doi.org/10.20944/preprints202604.1631.v1
  5. Torres-Zurita, A., Vázquez-Montero, L., Gallego-López, L., Mediano-Rambla, M. D., & de la Cruz-Merino, L. (2023). Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: A case report. Frontiers in Immunology, 14, 1150128.
    https://doi.org/10.3389/fimmu.2023.1150128